Showing Articles for

Cancer

Lawyers shaking hands representing the Roundup litigation push for settlement.

Lawyers for Roundup Plaintiffs Push for Settlement

MedTruth Editors · September 28, 2022

Attorneys want Roundup litigation resolved, either through a global settlement or a return of the cases.

Legal Developments
A group of scientists in a lab representing Zantac expert testimony hearings.

Zantac Expert Testimony Hearings To Be Held

MedTruth Editors · September 27, 2022

These special hearings will determine which expert witnesses will be allowed to testify in the Zantac trials.

Legal Developments
Someone spraying a plant with Roundup representing Bayer winning a Roundup cancer trial.

Bayer Wins Multi-Plaintiff Roundup Cancer Trial

MedTruth Editors · September 23, 2022

The Missouri trial included three plaintiffs who have non-Hodgkin’s lymphoma, allegedly because of Roundup exposure.

Legal Developments
A woman holding textured breast implants representing additional breast implant cancers discovered.

Additional Breast Implant Cancers Discovered

MedTruth Editors · September 20, 2022

In addition to BIA-ALCL, a lymphoma associated with breast implants, numerous cancers have been detected in tissues surrounding breast implants.

News
The Department of Justice building representing lawmakers demanding an update on the J&J talcum powder probe.

Lawmakers Demand DOJ Update on J&J Talc Probe

MedTruth Editors · September 16, 2022

The investigation aims to determine if Johnson & Johnson misled the public about the risks of using its talcum-based products after claims that the asbestos-contaminated powder causes cancer.

Laws + Congress
A woman writing an amicus curiae brief in support of J&J's talcum powder cancer bankruptcy proceedings.

Pro-Business Nonprofit Backs J&J Bankruptcy Proceeding

MedTruth Editors · September 6, 2022

A legal nonprofit submitted a document in support of Johnson & Johnson’s bankruptcy proceedings surrounding the company's talcum powder cancer cases.

Legal Developments
Lawyers shaking hands at a table with paperwork representing the first Zantac trial ending in a settlement.

First Zantac Trial Ends in Settlement

MedTruth Editors · August 31, 2022

Joseph Bayer agreed to drop his lawsuit, which was scheduled to be held in an Illinois state court, after reaching a settlement of more than $500,000 with generic makers of Zantac.

Legal Developments
A woman checking her breast representing the Allergan breast implant MDL plaintiffs claiming breast implants caused them to develop cancer.

Allergan Compelled to Produce Documents in Breast Implant MDL

MedTruth Editors · August 25, 2022

Allergan must produce documents related to over 400 patients to inform the bellwether selection process. Plaintiffs claim Allergan breast implants caused them to develop cancer.

Legal Developments
J&J's talcum powder-based baby powder on the shelf in Thailand representing the global phase out of this product.

J&J Announces Global Talc Phase Out

MedTruth Editors · August 24, 2022

Starting in 2023, J&J will no longer sell talcum-based baby powder products anywhere in the world. These products have been discontinued in the U.S. and Canada since 2020.

News
The St Louis skyline from above representing the Roundup trial underway in Monsanto's hometown alleging Roundup causes cancer.

New Roundup Trial Underway in Monsanto’s Hometown

Guest Contributor · August 18, 2022

Three people who used Roundup and have since been diagnosed with different types of lymphoma are suing Monsanto. The trial takes place in St. Louis, the headquarters of Monsanto.

Legal Developments
Two firefighters using aqueous film-forming foam to fight a fire, representing the PFAS class action.

Firefighters File PFAS Class Action

MedTruth Editors · August 5, 2022

PFAS chemicals, which are resistant to breaking down naturally in the environment, may accumulate in human tissue and have been associated with various health complications.

News
A woman speaking in court holding documents representing the appeals court reversal of a mesothelioma decision against J&J.

Appeals Court Reverses $120 Million Mesothelioma Decision Against J&J

MedTruth Editors · August 3, 2022

The court ruled that Olson’s legal team did not present expert testimony that established sufficient evidence that Olson’s exposure to talcum in J&J’s products caused her health to deteriorate. 

Legal Developments
Image of a couple gardening representing the Alberta and Alva Pilliod Roundup cancer case.

Supreme Court Declines To Review $87M Pilliod Roundup Case

MedTruth Editors · July 8, 2022

The Supreme Court turned away Bayer’s appeal of Alva and Alberta Pilliod's Roundup cancer case.

Legal Developments
An elderly woman holding pack of Zantac pills representing the Zantac trial dates set in California.

Zantac Bellwether Dates Set in CA

MedTruth Editors · July 6, 2022

The first four Zantac trials in California have been set for 2023. Zantac users claim that they were unknowingly exposed to unsafe levels of NDMA.

Legal Developments
A vehicle on a farm spraying plants with Roundup weedkiller containing glyphosate.

EPA Ordered To Reconsider Glyphosate Safety

MedTruth Editors · June 29, 2022

The EPA must reexamine its 2020 findings that glyphosate, the main active ingredient in Monsanto’s Roundup weedkiller products, is “not likely” to cause cancer.

Laws + Congress
Image of a judge holding gavel representing the Oregon judge blocking media coverage of Roundup cancer trial.

Judge Blocks Media Coverage of Roundup Cancer Trial

MedTruth Editors · June 27, 2022

The judge decided the media coverage might put pressure on the jury, resulting in jurors potentially dropping out.

Legal Developments
A woman feeling her breast experiencing breast pain representing the FDA's new breast implant study on risks of BIA-ALCL.

FDA Announces New Breast Implant Study

MedTruth Editors · June 23, 2022

BIA-ALCL is a man-made cancer, a specific type of T-cell lymphoma, that is associated with textured breast implants.

News
Supreme court building representing the DOJ recommending the Roundup cancer award stand.

Supreme Court Urged To Let $25M Roundup Cancer Award Stand

MedTruth Editors · May 25, 2022

The U.S. Department of Justice has recommended that the lower court verdict be allowed to stand.

Legal Developments
Weedkiller being sprayed on crops representing the former Monsanto CEO testifying in a Roundup cancer trial.

Former Monsanto CEO Testifies in First Roundup Trial Outside California

MedTruth Editors · May 20, 2022

This is the first trial in which former CEO of Monsanto Hugh Grant, who ran the company for 15 years, will testify.

Legal Developments
Image of a person spraying basil representing a Roundup judge criticizing proposed false advertising settlement.

Roundup Judge Criticizes Proposed False Advertising Settlement

MedTruth Editors · April 27, 2022

The settlement would provide payments to consumers who purchased certain Roundup products and resolve a lawsuit claiming that Monsanto failed to warn users.

Legal Developments
St Louis park bench and grass representing Bayer settling Roundup cancer claims.

Bayer Settles Dozens of Roundup Cancer Claims

MedTruth Editors · April 20, 2022

In March, Bayer announced that of approximately 138,000 cancer claims filed by individuals, 107,000 had been resolved or deemed ineligible.

Legal Developments
Judge holding gavel representing the J&J talc bankruptcy appeals granted.

Judge Grants Fast-Track Appeal of J&J’s Talc Bankruptcy

MedTruth Editors · April 13, 2022

Judge Kaplan allowed plaintiffs who have alleged that J&J’s asbestos-contaminated talc products caused them to develop cancer to appeal his ruling

Legal Developments
French fries in a fryer representing the court ruling that there is not enough evidence acrylamide causes cancer.

Acrylamide Lawsuits Halted Over Inconclusive Cancer Claims

MedTruth Editors · March 31, 2022

The federal court ruled that there is not enough evidence proving that acrylamide, a substance that’s formed during the heating process of certain foods, causes cancer.

News
Person spraying tree with Roundup weedkiller representing Bayer petitioning a Roundup case.

Bayer Brings Second Roundup Verdict Petition to Supreme Court

MedTruth Editors · March 30, 2022

The company behind Roundup weedkiller, which thousands claim caused their cancer, is petitioning the nation’s high court to review a Roundup case for the second time.

Legal Developments
A prison inmate with handcuffs representing the asbestos experiment conducted by J&J.

J&J Tested Asbestos On Inmates, Unsealed Docs Reveal

MedTruth Editors · March 23, 2022

The company hired a doctor to test the effects of asbestos on the inmates’ skin against the effects of talc.

News
A woman taking a pill representing the Chantix class action dismissed.

Chantix Carcinogen Class Action Dismissed

MedTruth Editors · March 16, 2022

The complaint accused Pfizer of misrepresenting the safety of the drug to consumers by failing to properly test Chantix despite warnings from regulators.

News
Illustration of bankruptcy law-related objects, representing the bankruptcy court approving J&J's talcum powder case with its new entity.

Bankruptcy Court Approves J&J Talc Case

MedTruth Editors · March 8, 2022

The judge is allowing Johnson & Johnson to move forward with the bankruptcy process for the company's new entity, LTL Management.

Legal Developments
Image of a woman with a pill bottle representing the first Zantac lawsuits taking place in CA.

CA State Court Hears Zantac Lawsuits in October

MedTruth Editors · March 2, 2022

California will hold the first Zantac lawsuits in October of this year. Defendants are accused of failing to warn users about the drug's potential link to cancer.

Legal Developments
Image of a judge on laptop representing the talc committee motions declined by judge.

Judge Declines To Decide Talc Committee’s Motions

MedTruth Editors · February 8, 2022

Judge Freda L. Wolfson has declined to decide issues arising from the bankruptcy of J&J’s subsidiary, LTL Management.

Legal Developments
Image of a bald woman tying a headscarf representing Sanofi winning a Taxotere trial over hair loss claims.

Sanofi Wins Taxotere Trial Over Hair Loss Claims

MedTruth Editors · February 2, 2022

Over 12,000 individuals allege that the breast cancer drug Taxotere caused their permanent hair loss, and that manufacturer Sanofi was aware that this could be a side effect of the drug.

Legal Developments
Illustration of judges in court representing Roundup attorneys possibly facing malpractice.

Roundup Attorneys May Face Malpractice Claims For Failing to Produce Experts

MedTruth Editors · January 28, 2022

Judge Chhabria’s order stated that plaintiffs must produce an expert to support their claim that Roundup caused their non-Hodgkin's lymphoma.

Legal Developments
Image of the White House representing the Supreme Court asking the Solicitor General about the Roundup cancer trial.

Supreme Court Asks Biden Admin To Weigh In on Roundup Appeal

MedTruth Editors · January 25, 2022

The U.S. Supreme Court asked the Solicitor General for the administration's views on the Roundup cancer trial that awarded plaintiff Edwin Hardeman $25 million.

Legal Developments
Image of a woman spraying Roundup representing a boy's Roundup cancer claims.

Bayer Settles Boy's Roundup Rare Cancer Claims

MedTruth Editors · January 19, 2022

A mother claims her son developed Burkitt’s lymphoma from years of Roundup exposure.

Legal Developments
Image of researchers in a lab representing cancer researchers criticizing glyphosate approval in the EU.

Cancer Researchers Criticize Glyphosate Approval in the EU

MedTruth Editors · December 9, 2021

Europe’s leading cancer researchers are questioning the EU's decision to issue a positive safety review for glyphosate.

Research + Findings
Image of baby powder on a peach background representing talc advocates rejecting J&J settlement talks.

Talc Advocates Reject J&J Settlement Talks

MedTruth Editors · November 29, 2021

Johnson & Johnson will most likely have to wait until at least 2022 before it can restart to negotiate a resolution.

Legal Developments
Image of the Mississippi skyline representing the talc trial delayed by J&J.

J&J Allegedly Delaying Talc Trial in Mississippi

MedTruth Editors · November 17, 2021

Mississippi's Attorney General urged the Supreme Court to reject J&J's petition to delay the state’s seven-year talcum powder lawsuit.

Legal Developments
Image of a woman with ovarian cancer holding her uterus representing J&J's third talc powder trial win.

J&J Wins Third Post-Pandemic Talc Powder Ovarian Cancer Trial

MedTruth Editors · October 22, 2021

This marks J&J’s third ovarian cancer talc trial win since cases were resumed after pandemic lockdowns.

Legal Developments
Image of a woman taking a pink pill representing the Zantac class action.

Branded Zantac Makers Can’t Escape Class-Action, Judge Rules

MedTruth Editors · October 21, 2021

Zantac manufacturers are facing lawsuits filed by individuals who claim the drug causes cancer.

Legal Developments
Image of Philadelphia skyline representing J&J cleared in Pennsylvania talcum powder ovarian cancer trial.

J&J Cleared in PA Talc Trial

MedTruth Editors · October 5, 2021

A jury acquitted Johnson & Johnson of civil liability for one woman’s ovarian cancer.

Legal Developments
Image of two lawyers representing a judge preventing an injunction against J&J asset splitting.

Judge Prevents Injunction Against J&J Asset Splitting

MedTruth Editors · September 30, 2021

The plaintiffs argue that this financial maneuver would unlawfully shield Johnson & Johnson from any liability the company may owe for its talcum powder’s connection to ovarian cancer. 

Legal Developments
Image of a person holding Zantac pills representing the first zantac trials in the nation.

Dates Set for First Zantac Trials in the Nation

MedTruth Editors · September 29, 2021

The first Zantac cancer case has been scheduled for 2022.

Legal Developments
Image of a St. Louis courthouse representing the first J&J talcum powder trial in Missouri over ovarian cancer claims since the pandemic.

J&J Returns to Court In “Ground Zero” For Ovarian Cancer Lawsuits

MedTruth Editors · September 24, 2021

The first J&J talcum powder trial since before the pandemic has begun in Missouri over ovarian cancer claims.

Legal Developments
Image of a farmer spraying crops with Roundup representing the EPA report linking glyphosate to cancer.

Newly-Released Internal EPA Report Links Glyphosate to Cancer

MedTruth Editors · September 8, 2021

An internal EPA document from 2016 suggested that several studies reported elevated risks of non-Hodgkin's lymphoma associated with glyphosate exposure.

News
Image of baby powder representing the J&J $26.5 million talcum powder verdict.

J&J Hit With $26.5 Million Talc Verdict

MedTruth Editors · September 2, 2021

Christina Prudencio's lawyer claimed her terminal mesothelioma was rooted in Johnson & Johnson ignoring decades of proof that their talcum products were unsafe.

Legal Developments
Image of Johnson & Johnson building representing J&J concealing talcum powder risks to preserve brand image.

J&J Concealed Talc Risks To Preserve Brand Image, Philly Jury Told

MedTruth Editors · September 1, 2021

The plaintiff in a Philadelphia trial claimed J&J was aware that its baby powder was associated with cancer risk but withheld that information for decades in order to protect its brand image.

News
Image of a woman holding talcum powder in her hand representing the supreme court denying J&J's talcum powder ovarian cancer appeal.

Supreme Court Allows Johnson & Johnson's $2 Billion Baby Powder Cancer Verdict

MedTruth Editors · June 7, 2021

The Supreme Court has allowed a $2.1 billion baby powder cancer verdict against Johnson & Johnson to stand.

News
Image of a bottle of talcum powder next to a stethoscope.

Johnson and Johnson Talcum Powder Lawsuits: Recent Developments

Guest Contributor · January 29, 2021

An update on lawsuits claiming J&J's talcum powder causes ovarian cancer.

Legal Developments
Image of a woman holding her stomach, representing fibroid surgery safety recommendations by the FDA.

Fibroid Removal Safety Recommendations Updated by FDA

Carah Wertheimer · January 7, 2021

The FDA has finalized safety recommendations for the use of power morcellators in surgeries to remove fibroids.

FDA Regulation
Image of talcum powder representing the Missouri supreme court rejecting J&J talc verdict appeal.

$2.1 Billion Talcum Powder Cancer Verdict Stands, J&J Appealing to Supreme Court

James Parker · November 12, 2020

Johnson & Johnson intends to appeal a record $2.1 billion talc verdict after striking out in the Missouri Supreme Court.

Legal Developments
Image of the new blood test that detects cancer up to 4 years before diagnosis.

New Blood Test Detects Cancer Up to 4 Years Before Diagnosis

Carah Wertheimer · September 18, 2020

A cutting-edge blood test can detect five common cancers up to four years before most people even know they have the disease.

News
Image of a woman with blue dyed hair representing the new study that says hair is not linked to cancer.

No Increased Risk of Most Cancers From Hair Dye, Study Says

Carah Wertheimer · September 14, 2020

A major study found no increased risk of most types of cancer in women who use permanent hair dye at home.

Research + Findings
A stock image of a woman with heartburn, representing Zantac lawsuit consolidation in California.

California Attorneys Seek to Consolidate Zantac Lawsuits

James Parker · June 12, 2020

Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.

Legal Developments
A photo of a hand throwing white powder in the air against a wooden fence backdrop, representing talcum powder statute of limitations.

How to Navigate Statutes of Limitation in Talc-Cancer Claims

Lynne Higby · May 27, 2020

Questions about the statute of limitations for ovarian cancer wrongful death claims have been raised by the families of women who used Johnson & Johnson's talcum powder products.

Legal Developments
A stock photo of talcum powder representing J&J's move to halt sales in the U.S. and Canada.

Johnson & Johnson Discontinues Talcum Powder in the U.S. & Canada

Carah Wertheimer · May 19, 2020

J&J will withdraw its signature talcum powder from North American markets, insisting the product is safe despite nearly 20,000 lawsuits alleging that asbestos-contaminated powder caused cancer.

News
Bald woman looks in the mirror, worried that her cancer chemotherapy treatment will be delayed because of the coronavirus.

Coronavirus Delays Chemotherapy for Cancer Patients

Benjamin Duong · April 16, 2020

Patients with cancer, already vulnerable with many dependent on regular treatment appointments, are facing delayed chemotherapy, surgeries and even outright cancellations.

News
A photo of a pharmacy, representing Zantac products no longer existing on pharmacy shelves.

Zantac and Ranitidine Products Removed from U.S. Market

Ashley Lombardo · April 1, 2020

On April 1, the U.S. Food and Drug Administration requested immediate removal of Zantac products from the U.S. market, including all prescription and over-the-counter medications containing ranitidine.

News
A photo of an empty courtroom due to the  COVID-19 shutdown of courts.

Johnson & Johnson Talc Appeal Unhindered by COVID-19 Shutdown

James Parker · March 30, 2020

A Missouri appellate court set an April 24 date for Johnson & Johnson’s $4.69 billion talc appeal, despite the Missouri Supreme Court’s cancellation of all April arguments to reduce COVID-19 exposure.

Legal Developments
Photo of a woman holding her dyed hair, representing the cancer risk linked to hair dyes and straighteners.

Chemical Hair Dyes and Straighteners May Increase Breast Cancer Risk

Benjamin Duong · March 2, 2020

Use of hair dyes and chemical hair straighteners may be associated with an increased risk of breast cancer, with black women being at an increased risk compared to white women.

Research + Findings
Woman on laptop reading MT weekly's latest topics on J&J Asbestos Settlement, EPA to Regulate PFAS.

MT Weekly: J&J Asbestos Settlement, EPA to Regulate PFAS

Carah Wertheimer · February 25, 2020

This week, MedTruth provides updates on the latest baby powder settlement, the EPA's new regulations on PFAS, plus a study on the impacts of chemical exposure during pregnancy.

News
A black and white photo of the tools in the OncoGenesis cervical cancer screening test which can be taken at home due to improving technology

iPap: The Emerging Future of Cervical Cancer Screening Technology

Tess Francke · January 21, 2020

A new, at-home cervical cancer screening test may just revolutionize early detection, especially in international markets that lack the infrastructure to provide easy access to doctors and regular pap smear tests.

Women's Health
A photo of a truck storing Zantac in the sun, as exposure to heat during storage and transportation causes the heartburn medication to become contaminated with NDMA.

Exposure to Heat During Storage Causes Zantac Contamination

Benjamin Duong · January 14, 2020

Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.

News
Woman reading study about talcum powder and ovarian cancer which underrepresents populations of color.

Study Exploring Talc-Cancer Link Underrepresents Populations of Color

Benjamin Duong · January 13, 2020

A recent baby powder study found an insignificant link between the substance and ovarian cancer, but the study has limitations, including underrepresenting populations of color.

Research + Findings
A photo of an Asian pharmacist removing medications from the pharmacy shelf, representing the recent news around the FDA Ranitidine recall.

More Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall

James Parker · January 13, 2020

Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.

FDA Regulation
A photo of a woman sitting and facing a public meeting, representing the pending FDA asbestos identification meeting on asbestos in talc.

FDA Schedules Public Meeting to Assess Testing for Asbestos in Talc

James Parker · January 13, 2020

The public meeting may be crucial to qualifying expert witnesses for thousands of plaintiffs involved in national talcum powder cases.

FDA Regulation
A photo of white pills, representing the FDA's metformin probe to assess if it contains unsafe levels of NDMA.

FDA Metformin Probe Investigates Potential NDMA Hazard

James Parker · January 8, 2020

An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.

FDA Regulation
A photo of a justice scale representing the Los Angeles jury verdict which found in favor of Johnson & Johnson in a recent mesothelioma cancer case.

Los Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit

James Parker · December 17, 2019

A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.

Legal Developments
A photo of diverse women's hands to represent attention on Breast Cancer Awareness Month 2019 and AiRS Foundation Advocacy.

Breast Cancer Awareness Month 2019 Explores All Reconstruction Options

S. Nicole Lane · October 16, 2019

This October, in honor of Breast Cancer Awareness Month, MedTruth recognizes the AiRS Foundation, which supports cancer survivors by providing information and financial aid to those considering reconstruction. It's important to note that reconstruction isn't the only option. Some women are taking social media by storm, advising women to "choose flat."

Health Features
Photo of Cancer Patient as she Enters Data into New Patient Reporting Technology Noona for Remote Care in Rural Areas

New Patient Reporting Technology Empowers Cancer Patients, Offering Remote Care

Tess Francke · October 8, 2019

Recent studies have found that rural cancer patients face challenges in accessing quality care over their metropolitan counterparts, which may impact life expectancy. Noona, a new system designed to provide cancer patients care and symptom assessment from the comfort of their own home, may just change that.

MedTech
Group of chickens next to a barn representing eating chicken over beef to reduce risk of breast cancer

Worried About Breast Cancer? Science Says Eat More Chicken, Less Red Meat

Carah Wertheimer · October 8, 2019

Research shows that women who consumed poultry rather than red meat had a significantly lower risk of breast cancer.

Research + Findings
An illustration of a patient undergoing adaptive radiotherapy, which may be the future of cancer treatment.

Adaptive Radiotherapy: Cancer Treatment May Be Safer, More Accessible

Benjamin Duong · August 21, 2019

Adaptive radiotherapy is a form of personalized radiation therapy for cancer treatment. Although still in its early stages, clinicians hope that with further development to imaging methods, this form of cancer treatment will be a safer option to target tumors while minimizing tissue damage.

Research + Findings
Image of ovary under microscope in a laboratory after ovarian cancer cells show mutation from talc exposure.

In the Lab: Ovarian Cancer Cells Show Mutation from Talc Exposure

Tess Francke · June 24, 2019

The link between talc powder and ovarian cancer has been warned about for years. Now, a recent study identifying evidence of cell mutation shows the way talc powder promotes the generation of ovarian cancer cells. This is the first study to confirm the cellular effect of talc.

Research + Findings
A photo of woman getting blood tested after researchers reveal new blood test for cancer detection.

Researchers Develop New Blood Test to Detect Cancer in 10 Minutes

Tess Francke · April 11, 2019

It's a quest to detect multiple types of cancer in its early stages with the simple blood test that would take under 10 minutes to report results. Researchers say it will be at least five years before there is sufficient data to show whether it can work.

News
A photo of two women, one who is a cancer survivor, to demonstrate why it's important to learn about ovarian cancer.

Why We Still Aren’t Educated Enough on Ovarian Cancer

S. Nicole Lane · November 14, 2018

A recent report found that many women don’t know that much about ovarian cancer whatsoever.

Women's Health
Pink illustration of the female reproductive system as it depicts the way ovarian cancer in fallopian tubes may be the starting point.

Preliminary Study Finds Ovarian Cancer May Start in Fallopian Tubes

Ashley Lombardo · October 25, 2017

An ovarian cancer study indicates the disease may originate in the fallopian tubes. Scientists used genome sequencing to examine DNA errors.

Research + Findings